Research location
Oss
Netherlands
Advertisement
Research activity in Oss
NetherlandsCureCurrent currently publishes aggregate city-level research activity for this location: 10 trials and 10 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Oss
10 linked trials · page 1 of 1Image-guided De-escalation of Neo-adjuvant Chemotherapy in HER2-positive Breast Cancer: the TRAIN-3 StudyNCT03820063 · 2019-02-27 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study Into the Effectivity and Safety of Firmagon, Prescribed for Treatment of Patients With Advanced Prostate CancerNCT01215526 · 2010-10-01 · 1 site observation
COMPLETED
The CHIPS Trial (Control of Hypertension In Pregnancy Study)NCT01192412 · 2009-04-01 · 1 site observation
COMPLETED
Effectiveness of an Active Lifestyle Promotion Program for Patients With Parkinson's DiseaseNCT00748488 · 2008-09-01 · 1 site observation
COMPLETED
Efficiency of Physiotherapeutic Care in Parkinson's DiseaseNCT00330694 · 2006-05-01 · 1 site observation
COMPLETED
Faslodex Observations During Regular Use by Advanced Mammacarcinoma PatientsNCT00241462 · 2005-06-01 · 1 site observation
TERMINATED
DIALOOG: Crestor in Patients With Diabetes Mellitus Type 2: Lowering of LDL-C Levels to New European GuidelinesNCT00233649 · 2004-05-01 · 1 site observation
COMPLETED
Crestor Versus Placebo in Subjects With Heart FailureNCT00206310 · 2003-09-01 · 1 site observation
COMPLETED
SERETIDE 50/500mcg Versus Tiotropium Bromide On Exacerbation Rates In Severe Chronic Obstructive Pulmonary DiseaseNCT00361959 · 2003-06-01 · 1 site observation
COMPLETED
Adherence to Guidelines for Antibiotic Use in Respiratory Infections at HospitalsNCT00129883 · 2002-09-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.